Luke Evnin's Net Worth

$3.08 Billion

Estimate Recalculated Feb 23, 2024 07:02PM EST

Who is Luke Evnin?

Luke Evnin has an estimated net worth of $3.08 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., ARYx Therapeutics, Inc., PEPLIN INC, CRYOCOR INC, HEMOSENSE INC, COTHERIX INC, TERCICA INC, BARRIER THERAPEUTICS INC, TriVascular Technologies, Inc., RIGEL PHARMACEUTICALS INC, Entrada Therapeutics, Inc., Dyne Therapeutics, Inc., PHARMATHENE, INC, AVEO PHARMACEUTICALS INC, XCYTE THERAPIES INC, PONIARD PHARMACEUTICALS, INC., ACORDA THERAPEUTICS INC, ARATANA THERAPEUTICS, INC., KALOBIOS PHARMACEUTICALS INC, Conatus Pharmaceuticals Inc, Epizyme, Inc., Cerecor Inc., CRITICAL THERAPEUTICS INC, Pharmasset Inc, Zalicus Inc., AFFYMAX INC, Somaxon Pharmaceuticals, Inc., HELICOS BIOSCIENCES CORP, SENORX INC, OSCIENT PHARMACEUTICALS CORP, Alsius Corp, Omrix Biopharmaceuticals, Inc., MEMORY PHARMACEUTICALS CORP, Harpoon Therapeutics, Inc., VIACELL INC, METROPCS COMMUNICATIONS INC, EnteroMedics Inc, iTeos Therapeutics, Inc., Restore Medical, Inc., Radius Health, Inc., Repare Therapeutics Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, Pacira Pharmaceuticals, Inc., TCR2 THERAPEUTICS INC., TURMERIC ACQUISITION CORP., Werewolf Therapeutics, Inc., Oncorus, Inc., IPASS INC, CHIASMA, INC, IDENIX PHARMACEUTICALS INC, and METABASIS THERAPEUTICS INC.

SEC CIK

Luke Evnin's CIK is 0001134657

Past Insider Trading and Trends

2007 was Luke Evnin's most active year for acquiring shares with 35 total transactions. Luke Evnin's most active month to acquire stocks was the month of June. 2021 was Luke Evnin's most active year for disposing of shares, totalling 100 transactions. Luke Evnin's most active month to dispose stocks was the month of August. 2019 saw Luke Evnin paying a total of $14,121,250.25 for 8,076,674 shares, this is the most they've acquired in one year. In 2007 Luke Evnin cashed out on 44,712,617 shares for a total of $98,290,150.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9,078.27%
2.67M
$17.00
2.7M
Oct 10
Form 3
0
0
No matching records found

ARYx Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Sep 30
Form 4
0
0
Aug 13
Form 4
+49.98%
1.79M
$2.20
$3,932,962.00
5.36M
Nov 14
Form 4
3.58M
$10.00
3.58M
Nov 13
Form 3
0
0
No matching records found

PEPLIN INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.42M
0
Nov 11
Form 4
+0.07%
2.25K
$8.11
$18,233.80
3.42M
Feb 11 - Feb 12
Form 4
+0.03%
1K
$8.00
$7,992.00
3.42M
Feb 9
Form 4
+0.08%
2.65K
$7.80
$20,654.40
3.42M
Feb 5
Form 4
+0.23%
7.71K
$8.04
$61,948.00
3.41M
Jan 23 - Jan 27
Form 4
+0.10%
3.52K
$8.07
$28,369.80
3.41M
Jan 21 - Jan 22
Form 4
+0.29%
9.88K
$8.14
$80,402.20
3.4M
Jan 15 - Jan 20
Form 4
+0.20%
6.91K
$7.03
$48,584.33
3.39M
Jan 13
Form 3/A
0
0
Form 3
0
0
No matching records found

CRYOCOR INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.03M
$1.35
-$4,087,910.70
0
May 28
Form 4
+3.29%
96.55K
$5.14
$496,272.14
3.03M
Apr 24
Form 4
+1,528.63%
2.75M
$8.37
$1,020,637.80
2.93M
Jul 19
Form 4
180K
$11.00
$1,980,000.00
180K
Jul 13
Form 3
0
0
No matching records found

HEMOSENSE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.83M
0
Nov 6
Form 4
-11.05%
-475.40K
$12.77
-$6,069,784.88
3.83M
Sep 12 - Sep 13
Form 4
4.3M
$5.50
4.3M
Jul 1
Form 3/A
0
0
Form 3
0
0
No matching records found